Search – Page 188 – Indianapolis Business Journal

Home » Search

Articles

IEDC using helicopters to show off ‘mega-sites’ for Indy 500 weekend

May 26, 2023 | Mickey Shuey

The Indiana Economic Development Corp. is rolling out the red carpet for businesses eying sites in central Indiana as part of a strategy centered on the pageantry of the Indianapolis 500.

2023 Innovation Issue: From humans to cows

May 26, 2023 | Daniel Bradley

In 2017, Donahue was part of a team that performed Indiana’s first intravaginal embryo culture with an FDA-approved device that allowed embryos to grow in a device inside the patient rather than in an incubator in a lab.

Eli Lilly settles class-action insulin lawsuit for $13.5M

May 31, 2023 | John Russell

Under the agreement, Lilly has agreed to continue its cap on out-of-pocket costs for its users at $35 a month for four years.

Medicare to expand coverage for new class of costly Alzheimer’s drugs

June 1, 2023 | The Washington Post

Groups such as the Alzheimer’s Association have pushed Medicare to cover the new Alzheimer’s drugs—including those cleared on an expedited basis—saying that the FDA should be the final arbiter of safety and efficacy of drugs.

Fishers-based AfterSchool HQ lands $3M seed investment

June 2, 2023 | Susan Orr

Fishers-based education-tech firm AfterSchool HQ recently landed $3 million in outside investment, bringing the company’s fundraising total to $4.3 million since its launch in late 2017.

Editorial: Unbridled return of the Indy 500 revs region’s economic engines

June 2, 2023

The challenge now is to keep up the economic momentum to fully restore the city’s vitality downtown and elsewhere.

Lilly battling rivals for breast-cancer patients

June 9, 2023 | John Russell

The Indianapolis-based pharmaceutical giant is spending hundreds of millions of dollars to win over patients with an extensive advertising campaign.

Insurers clamping down on doctors who prescribe Ozempic for weight loss

June 11, 2023 | The Washington Post

Indianapolis-based Elevance Health, which operates Anthem plans, said that in most cases, it won’t cover Ozempic unless a patient is diagnosed with diabetes and has tried another medication to manage it, but physicians can still prescribe it.

Inflation Reduction Act foes race to repeal climate, drug pricing programs

June 18, 2023 | The Washington Post

A growing roster of corporate and political foes has started to lay siege to the law, hoping to erode some of its key provisions before they can take effect.

Lilly to buy California immunology company in $2.4B deal

June 20, 2023 | John Russell

Dice has a proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology.

Lebanon to consider special zoning classification for part of LEAP district

June 21, 2023 | Daniel Bradley

The LEAP Lebanon Innovation District Planned Unit Development would set development standards for about 6,000 acres of the planned high-tech district in Boone County along Interstate 65 between Indianapolis and Lafayette.

Lennar Homes planning 96 townhouses in Lebanon near LEAP district

June 22, 2023 | Daniel Bradley

The plan commission voted unanimously to recommend the rezoning request for Corbett Towns, which include 17 new buildings on 12 acres of undeveloped land.

IEDC’s funding requests for major LEAP District projects approved

June 23, 2023 | Peter Blanchard

The Indiana Economic Development Corp. received the green light Thursday to spend $122 million to purchase roughly 1,000 acres of land as part of an incentive package to lure a global semiconductor manufacturer to central Indiana.

State budget panel weighs risks of additional $200M in IEDC requests

June 23, 2023 | Leslie Bonilla Muñiz, Indiana Capital Chronicle

The quasi-public agency behind a mammoth innovation district reassured budget experts Thursday on the risks it’s taking to win competitive business investments and speedily close those deals.

Next step for obesity drug makers replacing needles with pills

June 26, 2023 | Associated Press

Medical experts predict the pills will be popular, especially among people who want to lose weight but are fearful of needles.

Eli Lilly to acquire Massachusetts-based biotech for $309M

June 29, 2023 | John Russell

The Indianapolis-based drugmaker said it will acquire Sigilon Therapeutics Inc., a six-year-old startup that is developing a technology to help type 1 diabetes patients restore insulin production over sustained periods.

Drugmakers warn new law will deter discoveries

June 30, 2023 | John Russell

David Ricks, CEO of Indianapolis-based drugmaker Eli Lilly and Co., is turning up the volume on his concerns over a new law that would allow Medicare, for the first time, to negotiate drug prices.

IBJ Podcast: Lilly in middle of big battle over future of drug prices for seniors

July 3, 2023

In this week’s edition of the IBJ Podcast, reporter John Russell discusses Medicare’s new power to negotiate drug prices and its effects on patients, drug makers and the rest the health care industry. Eli Lilly and Co. would like to see some changes.

State considers adding LEAP districts beyond Lebanon

July 7, 2023 | Peter Blanchard and Mickey Shuey

Officials are eyeing a few commercial and industrial parks they believe could benefit from the model that puts the state in charge of acquiring land and master-planning a site.

Weight-loss drugs probed over reports of suicidal thoughts

July 10, 2023 | Bloomberg News

The EMA said it would consider whether its review should be extended to other drugs in the same class, known as GLP-1 receptor agonists. Indianapolis-based Eli Lilly and Co.’s Mounjaro is among them.

« Previous 1 … 186 187 188 189 190 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'